Considering the role of HIF-1α in determining tumor proliferation and invasiveness, as well as the association of high expression of these mesenchymal markers with worse survival of GBM patients [24], the reduced HIF-1α expression could be associated with a less aggressive GBM progression. Here, HIF1A is linked to neoplasm.